Use of tumor necrosis factor ‐alpha inhibitors during pregnancy among women who delivered live born infants

ConclusionThere was a preference for etanercept among pregnancies with AS/JIA/PsA/PsO/RA, despite the availability of other TNFis. Decline in TNFi use after the first trimester may be related to the desire to reduce TNFis transplacental transfer and to minimize infection risk to the fetus or baby associated with live vaccine immunizations after birth.

Source: Pharmacoepidemiology and Drug Safety - November 14, 2018 Category: Drugs & Pharmacology Authors: Efe Eworuke, Genna Panucci, Margie Goulding, Rosemarie Neuner, Sengwee Toh Tags: ORIGINAL REPORT Source Type: research